These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12512978)

  • 1. Optimal therapy of primary ocular lymphoma.
    Plowman PN; Taylor A; Jackson AS; Lightman S; Pavesio C
    Clin Oncol (R Coll Radiol); 2002 Dec; 14(6):521. PubMed ID: 12512978
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapy of PCNSL at the Massachusetts General Hospital with high dose methotrexate and deferred radiotherapy.
    Hochberg FH; Tabatabai G
    Ann Hematol; 2001; 80 Suppl 3():B111-2. PubMed ID: 11757690
    [No Abstract]   [Full Text] [Related]  

  • 3. Non-hodgkins lymphoma.
    Mead G; Woodcock J; Young C
    Clin Evid; 2003 Jun; (9):1-21. PubMed ID: 12967352
    [No Abstract]   [Full Text] [Related]  

  • 4. Multiagent chemotherapy in the salvage cure of ocular lymphoma relapsing after radiotherapy.
    Plowman PN; Montefiore DS; Lightman S
    Clin Oncol (R Coll Radiol); 1993; 5(5):315-6. PubMed ID: 8305342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advanced abdominal non-Hodgkin's lymphoma in the child. Features and response to treatment].
    Lobo-Sanahuja F; García I; Vargas G; Barrantes J; Jiménez E; Jiménez R
    Sangre (Barc); 1988 Jun; 33(3):196-201. PubMed ID: 3175816
    [No Abstract]   [Full Text] [Related]  

  • 7. Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients.
    Todeschini G; Ambrosetti A; Meneghini V; Pizzolo G; Menestrina F; Chilosi M; Benedetti F; Veneri D; Cetto GL; Perona G
    J Clin Oncol; 1990 May; 8(5):804-8. PubMed ID: 1692089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of three polychemotherapy programs in non-Hodgkin's lymphomas.
    Konopka L; Pawelski S
    J Chemother; 1989 Jul; 1(4 Suppl):1259-62. PubMed ID: 16312857
    [No Abstract]   [Full Text] [Related]  

  • 9. The F-MACHOP regimen in advanced diffuse aggressive lymphomas: summary of ten years' experience at a single institution.
    Guglielmi C; Amadori S; Martelli M; Papa G; Mandelli F
    Leukemia; 1991; 5 Suppl 1():102-4. PubMed ID: 1890858
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment and prognosis of orbital non-Hodgkin's lymphomas.
    Platanias LC; Putterman AM; Vijayakumar S; Recant W; Weichselbaum RR; Bitran JD
    Am J Clin Oncol; 1992 Feb; 15(1):79-83. PubMed ID: 1372464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe chemotherapy-induced recall of radiation mucositis in a patient with non-Hodgkin's lymphoma of Waldeyer's ring.
    Eifel PJ; McClure S
    Int J Radiat Oncol Biol Phys; 1989 Oct; 17(4):907-8. PubMed ID: 2476427
    [No Abstract]   [Full Text] [Related]  

  • 12. CHOP versus intensive regimens in non-Hodgkin's lymphoma.
    Longo DL; DeVita VT; Young RC
    N Engl J Med; 1993 Aug; 329(8):580-1; author reply 581-2. PubMed ID: 7687747
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.
    Fisher RI; Gaynor ER; Dahlberg S; Oken MM; Grogan TM; Mize EM; Glick JH; Coltman CA; Miller TP
    N Engl J Med; 1993 Apr; 328(14):1002-6. PubMed ID: 7680764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Termination of the treatment of children with non-Hodgkin's lymphoma after its recurrence].
    Dłuzniewska A; Balwierz W; Kwinta J
    Pol Tyg Lek; 1989 Oct 2-16; 44(40-42):882-4. PubMed ID: 2487943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical phase II study of ProMACE-CytaBOM.
    Dahlberg S; Miller TP; Fisher RI
    J Clin Oncol; 1991 May; 9(5):888. PubMed ID: 1707958
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
    Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
    Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypopyon uveitis and iris nodules in non-Hodgkin's lymphoma: ocular relapse during systemic remission.
    Verity DH; Graham EM; Carr R; van der Walt JD; Stanford MR
    Clin Oncol (R Coll Radiol); 2000; 12(5):292-4. PubMed ID: 11315712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Southwest Oncology Group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomas.
    Miller TP; Dana BW; Weick JK; Jones SE; Coltman CA; Dahlberg S; Fisher RI
    Semin Hematol; 1988 Apr; 25(2 Suppl 2):17-22. PubMed ID: 2456619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CBVPM/AVBP versus HCOMLA chemotherapy in non-Hodgkin lymphoma patients.
    Pawelski S; Konopka L; Pakulska J; Gutkowska J
    Chemioterapia; 1987 Jun; 6(2 Suppl):716-9. PubMed ID: 2475265
    [No Abstract]   [Full Text] [Related]  

  • 20. Minimizing toxicity of MACOP-B.
    Connors JM; Klimo P
    J Clin Oncol; 1987 Aug; 5(8):1302-3. PubMed ID: 2442319
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.